BACKGROUND AND OBJECTIVES: To avoid costly evaluation of healthy individuals, efficient methods of screening for incident dementia must combine adequate sensitivity and high specificity. Two-stage screening may offer improvements over single-stage methods. We therefore investigated a two-stage screening protocol for incident dementia among 3,308 elderly. METHODS: We administered the Modified Mini-Mental-State (3MS) or, rarely, Jorm's IQCODE, to a validation sample of 441 high-risk respondents. Informants then completed the Dementia Questionnaire (DQ). Finally, all 441 sample members underwent physical, neurologic, and neuropsychologic assessment. We studied the sensitivity and specificity of the 3MS/IQCODE and DQ using Receiver-Operating Characteristic analyses. RESULTS: A 3MS cut point of 82/83 (of 100) yielded sensitivity and specificity of 91.5 and 90.1%. With 3MS scores of < or =82, a DQ cut point of 2/3 (of five) yielded conditional sensitivity and specificity of 90.2 and 55.3%. Combining these instruments yielded sensitivity and specificity of 82.5 and 95.6%. Age stratification and use of longitudinal decline score criteria did not materially improve these figures. CONCLUSIONS: The improved specificity of the two-stage approach offers economies that are attractive, particularly if sensitivity can be enhanced, for example, by examination of a high-risk validation sample.
BACKGROUND AND OBJECTIVES: To avoid costly evaluation of healthy individuals, efficient methods of screening for incident dementia must combine adequate sensitivity and high specificity. Two-stage screening may offer improvements over single-stage methods. We therefore investigated a two-stage screening protocol for incident dementia among 3,308 elderly. METHODS: We administered the Modified Mini-Mental-State (3MS) or, rarely, Jorm's IQCODE, to a validation sample of 441 high-risk respondents. Informants then completed the Dementia Questionnaire (DQ). Finally, all 441 sample members underwent physical, neurologic, and neuropsychologic assessment. We studied the sensitivity and specificity of the 3MS/IQCODE and DQ using Receiver-Operating Characteristic analyses. RESULTS: A 3MS cut point of 82/83 (of 100) yielded sensitivity and specificity of 91.5 and 90.1%. With 3MS scores of < or =82, a DQ cut point of 2/3 (of five) yielded conditional sensitivity and specificity of 90.2 and 55.3%. Combining these instruments yielded sensitivity and specificity of 82.5 and 95.6%. Age stratification and use of longitudinal decline score criteria did not materially improve these figures. CONCLUSIONS: The improved specificity of the two-stage approach offers economies that are attractive, particularly if sensitivity can be enhanced, for example, by examination of a high-risk validation sample.
Authors: Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2006-03-05 Impact factor: 3.568
Authors: Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2013-08-15 Impact factor: 21.566
Authors: Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor Journal: J Neurol Neurosurg Psychiatry Date: 2006-12-18 Impact factor: 10.154
Authors: Sarah A Gaussoin; Mark A Espeland; John Absher; Barbara V Howard; Beverley M Jones; Stephen R Rapp Journal: Int J Geriatr Psychiatry Date: 2011-03-18 Impact factor: 3.485
Authors: Joshua Matyi; JoAnn T Tschanz; Gail B Rattinger; Chelsea Sanders; Elizabeth K Vernon; Chris Corcoran; John S K Kauwe; Mona Buhusi Journal: J Gerontol A Biol Sci Med Sci Date: 2017-11-09 Impact factor: 6.053
Authors: Muhammad Haroon Burhanullah; JoAnn T Tschanz; Matthew E Peters; Jeannie-Marie Leoutsakos; Joshua Matyi; Constantine G Lyketsos; Milap A Nowrangi; Paul B Rosenberg Journal: Am J Geriatr Psychiatry Date: 2019-05-23 Impact factor: 4.105
Authors: Joann T Tschanz; Roxane Pfister; Joseph Wanzek; Chris Corcoran; Ken Smith; Brian T Tschanz; David C Steffens; Truls Østbye; Kathleen A Welsh-Bohmer; Maria C Norton Journal: Int J Geriatr Psychiatry Date: 2012-10-04 Impact factor: 3.485
Authors: Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer Journal: Arch Neurol Date: 2009-11
Authors: Manjula Kurella Tamura; Kristine Yaffe; Chi-Yuan Hsu; Jingrong Yang; Stephen Sozio; Michael Fischer; Jing Chen; Akinlolu Ojo; Jennifer DeLuca; Dawei Xie; Eric Vittinghoff; Alan S Go Journal: Am J Kidney Dis Date: 2016-03-10 Impact factor: 8.860